Abstract: Disclosed herein are systems and methods to remove material of interest, including blood clots, from a body region, including but not limited to the circulatory system for the treatment of pulmonary embolism (PE), deep vein thrombosis (DVT), cerebrovascular embolism, and other vascular occlusions.

Abstract: The present invention relates to benzimidazol-2-amines of general formula (I), in which R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12 are as defined herein, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of neoplasms, as a sole agent or in combination with other active ingredients.

Abstract: Disclosed herein are compositions and methods for increasing recovery, or flowback, of hydrocarbon compounds from hydrocarbon-containing subterranean reservoirs. The flowback compositions include an anionic sulfonated surfactant, an amphoteric surfactant, water, and a coupling agent. The flowback compositions convert oil-wet rocks to water-wet, yet exhibit a low tendency of composition components to sorb to the rock. The flowback compositions do not cause formation of emulsions with hydrocarbon compounds within the subterranean environment. The flowback compositions are particularly useful for increasing the yield of hydrocarbons recovered from tight shale reservoirs.

Abstract: The present invention relates to benzimidazol-2-amines of general formula (I): in which R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12 are as defined herein, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of neoplasms, as a sole agent or in combination with other active ingredients.

Abstract: A sensor system for a vehicle including a first camera sensor and a second camera sensor configured to be mounted spaced apart from one another on a vehicle. A sensor module of the sensor system is configured to generate a three-dimensional image of an environment about the vehicle based on data collected by the first camera sensor and the second camera sensor.

Abstract: Polycrystalline diamond compacts (“PDCs”) include a polycrystalline diamond (“PCD”) table in which cobalt is alloyed with phosphorous to improve the thermal stability of the PCD table. For example, a PDC includes a substrate and a PCD table including an upper surface spaced from an interfacial surface that is bonded to the substrate. The PCD table includes a plurality of diamond grains defining a plurality of interstitial regions. The PCD table further includes an alloy comprising at least one Group VIII metal and phosphorous. The alloy is disposed in at least a portion of the plurality of interstitial regions.

Abstract: A sensor array for an autonomous vehicle. The sensor array includes a center sensor mounted to a center sensor mounting device, which is configured to telescope to adjust a height of the center sensor. A first side sensor is mounted to a first side sensor mounting device, which is configured to pivot to adjust an angle of the first side sensor. A second side sensor is mounted to a second side sensor mounting device, which is configured to pivot to adjust an angle of the second side sensor.

Abstract: Systems and methods can remove material of interest, including blood clots, from a body region, including but not limited to the circulatory system for the treatment of pulmonary embolism (PE), deep vein thrombosis (DVT), cerebrovascular embolism, and other vascular occlusions.

Abstract: A wireless power transfer system for charging a battery positioned in a vehicle may include a primary side network, a secondary side network, detection coils, and a charge monitor controller. The secondary side network may be configured to receive power from the primary side network by way of inductively coupling between a transmitting coil of the primary side network and a receiving coil of the secondary side network. The detection coils may be coupled to magnetic cores provided with at least one of the primary side network or the secondary side network. The detection coils may output at least one voltage signal based on the inductively coupling between the transmitting coil and the receiving coil. The charge monitor controller may determine a system diagnosis status based on the at least one voltage signal from the detection coils.

Abstract: Systems and methods can remove material of interest, including blood clots, from a body region, including but not limited to the circulatory system for the treatment of pulmonary embolism (PE), deep vein thrombosis (DVT), cerebrovascular embolism, and other vascular occlusions.

Abstract: A system and method are provided and include a subject vehicle having a sensor that senses information about an environment of the subject vehicle. An actuator rotates the sensor according to a commanded angle. A controller determines a position and a trajectory path of the subject vehicle, determines an adaptive point along the determined trajectory path based on the position, and generates the commanded angle for the actuator to rotate the sensor towards the adaptive point.

Abstract: The present invention relates to benzimidazol-2-amines of general formula (I) in which R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12 are as defined herein, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of neoplasms, as a sole agent or in combination with other active ingredients.

Abstract: A method for identifying a set of interpolation point data points from training data for a sparse Gaussian process model, encompassing the following tasks: successively selecting training data points from the set of training data for acceptance into or exclusion from a set of interpolation point data points in accordance with a selection criterion; and terminating selection when a termination criterion exists; the selection criterion depending on a divergence between a target value of the selected training data point and a function value, at the selected training data point, of the Gaussian process model based on the respectively current set of interpolation point data points.

Abstract: A system and method are provided and include a subject vehicle having a sensor that senses information about an environment of the subject vehicle. An actuator rotates the sensor according to a commanded angle. A controller determines a position and a trajectory path of the subject vehicle, determines an adaptive point along the determined trajectory path based on the position, and generates the commanded angle for the actuator to rotate the sensor towards the adaptive point.

Abstract: A double-sided LCC compensation network and a tuning method are proposed for a wireless power transfer system. With the proposed topology, the resonant frequency is independent of coupling coefficient and load conditions. The parameter values are tuned to realize zero voltage switching (ZVS) for the sending side switches. A wireless charging system with up to 7.7 kW output power was designed and built using the proposed topology and achieved 96% efficiency from DC power source to battery load.

Abstract: Disclosed are various embodiments for a node selection application. Utility nodes are selected from a taxonomy according to utility scores with respect to a search query. Relevant nodes are selected from the taxonomy according to relevance scores with respect to the search query. A collection of taxonomy nodes is recommended according to a convergence between the utility nodes and the relevant nodes.

Abstract: Systems and methods can remove material of interest, including blood clots, from a body region, including but not limited to the circulatory system for the treatment of pulmonary embolism (PE), deep vein thrombosis (DVT), cerebrovascular embolism, and other vascular occlusions.

Abstract: Exemplary methods, apparatuses, and systems receive a first input/output (I/O) trace including storage addresses that were subject to a plurality of I/O requests from a first workload during a first period of time. The first I/O trace is run through a cache simulation using a plurality of simulated cache sizes. A first state of the cache simulation is stored upon completing the first I/O trace simulation. The first I/O trace is deleted in response to storing the first state. A second I/O trace including storage addresses that were subject to a plurality of I/O requests from the first workload during a second period of time is received. A cumulative miss ratio curve for the first workload is generated by loading the stored first state as a starting point for simulating the second I/O trace and running the second I/O trace through the cache simulation.

Abstract: One embodiment relates to testing and verifying vibrator motor operation during manufacturing of a device and during in-the-field use. The test relies on an integrated motion sensor or other mechanical measurement circuitry, such as, for example, an accelerometer. In one embodiment, a speed determination for a vibrator motor performance during initial manufacture of the device. Subsequently, when vibration is detected during the in-the-field use, the vibration may be sampled using the integrated mechanical measurement circuitry. Once sampled, a speed may be determined based on a resonance of the sampled signal. Over time, the various speed determinations for the vibrator motor may be analyzed to determine an overall health of the vibrator motor. A threshold for detecting when the overall health of the vibration motor over time has degraded may be predetermined. A notification of a degradation of vibrator motor performance is sent to either a manufacturer or user of the mobile communications device.

Abstract: Systems and methods can remove material of interest, including blood clots, from a body region, including but not limited to the circulatory system for the treatment of pulmonary embolism (PE), deep vein thrombosis (DVT), cerebrovascular embolism, and other vascular occlusions.